Corneal Cross-Linking (CXL) is an advanced ophthalmic procedure designed to strengthen the cornea by increasing the natural bonds between collagen fibers. The treatment is most commonly used for keratoconus and other conditions associated with progressive corneal thinning and weakening.

During the procedure, riboflavin (vitamin B2) eye drops are applied to the cornea and activated with controlled ultraviolet (UV-A) light. This process increases corneal stability and helps prevent further deterioration of vision.

Key benefits include:

• Strengthening of corneal tissue

• Slowing or stopping disease progression

• Preservation of visual function

• Reduction in the need for more invasive surgery

Corneal Cross-Linking is a safe and effective treatment that plays a crucial role in preserving corneal integrity and supporting long-term eye health.

Corneal-Crosslinking – Recovery and Travel Recommendations

After corneal crosslinking, patients may experience pain, light sensitivity, tearing, and blurred vision during the first few days. Most patients can return to work or school within approximately 5–7 days, depending on discomfort and visual recovery. Vision may fluctuate for several weeks while the cornea continues to heal.

●      Patients are advised to remain in the country for at least 5–7 days after the procedure.

●      Air travel is not usually recommended during the first few days, especially while discomfort and light sensitivity are significant.

●      For longer journeys exceeding 4–6 hours, it is generally safer to wait until the protective contact lens is removed and the surgeon confirms proper healing.